UNRELATED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) WITH CLASS I ANTIGENIC MISMATCH WITH IN VIVO POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) FOR GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS: PROMISING STRATEGY TO TRANSPLANT PATIENTS WITH NON-MALIGNANT GENETIC DISEASES

UNRELATED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) WITH CLASS I ANTIGENIC MISMATCH WITH IN VIVO POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) FOR GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS: PROMISING STRATEGY TO TRANSPLANT PATIENTS WITH NON-MALIGNANT GENETIC DISEASES

Introduction: Despite the progress in Haploidentical Stem Cell Transplantation (HSCT), many patients do not have a suitable healthy family donor. Transplants from matched unrelated donors would be ideal, but they are not available to most patients. One emerging treatment option is to use mismatched...

Full description

Bibliographic Details
Main Authors: CMMSS Parrode, AS Ibanez, CM Lustosa, V Varjão, LL Quintino, LDS Domingues, MGAD Matos, G Zamperlini, RV Gouveia, A Seber
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137923011367

Internet

http://www.sciencedirect.com/science/article/pii/S2531137923011367

Similar Items